Personalis Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 6.4× Personalis Inc. Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| PSNL | RDY | |
|---|---|---|
Market Cap | $1.69B | $10.78B |
Volume | 3,817,236 | 2,724,343 |
Sector | Health | Health |
52-Week High | $18.38 | $15.38 |
52-Week Low | $5.04 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.52B | $10.68B |
Dividend Yield | — | 0.65% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →